Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Etiproston Tromethamine
1. 59619-81-7
2. Etiprostone
3. Etiproston [inn]
4. Prostavet
5. Tcu22w0apy
6. (z)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(e)-2-[2-(phenoxymethyl)-1,3-dioxolan-2-yl]ethenyl]cyclopentyl]hept-5-enoic Acid
7. Etiproston (inn)
8. (z)-7-((1r,2r,3r,5s)-3,5-dihydroxy-2-((e)-2-(2-(phenoxymethyl)-1,3-dioxolan-2-yl)vinyl)cyclopentyl)-5-heptenoic Acid
9. Etiprostonum
10. Etiprostone [inn-french]
11. Unii-tcu22w0apy
12. Etiprostonum [inn-latin]
13. Brn 1274276
14. Etiproston [mi]
15. Prostavet [veterinary] (tn)
16. Chembl2104285
17. Schembl11602088
18. Dtxsid501024232
19. Zinc30691625
20. 15-deoxy-15,15-ethylenedioxy-16-phenoxy-17,18,19,20-tetranor-pgf2-alpha
21. 15-deoxy-15,15-ethylenedioxy-16-phenoxy-17,18,19,20-tetranor-prostaglandin F2-alpha
22. D07932
23. 619e817
24. Q27289904
25. 15-deoxy-15, 15-ethylenedioxy-16-phenoxy-omega-tetranor Pgf-2alpha
26. 5-heptenoic Acid, 7-(3,5-dihydroxy-2-(2-(2-(phenoxymethyl)-1,3-dioxolan-2-yl)ethenyl)cyclopentyl)-, (1r-(1-alpha(z),2-beta(e),3-alpha,5-alpha))-
| Molecular Weight | 432.5 g/mol |
|---|---|
| Molecular Formula | C24H32O7 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 11 |
| Exact Mass | 432.21480336 g/mol |
| Monoisotopic Mass | 432.21480336 g/mol |
| Topological Polar Surface Area | 105 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 605 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
51
PharmaCompass offers a list of Etiproston API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Etiproston manufacturer or Etiproston supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Etiproston manufacturer or Etiproston supplier.
PharmaCompass also assists you with knowing the Etiproston API Price utilized in the formulation of products. Etiproston API Price is not always fixed or binding as the Etiproston Price is obtained through a variety of data sources. The Etiproston Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Etiproston manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Etiproston, including repackagers and relabelers. The FDA regulates Etiproston manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Etiproston API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Etiproston manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Etiproston supplier is an individual or a company that provides Etiproston active pharmaceutical ingredient (API) or Etiproston finished formulations upon request. The Etiproston suppliers may include Etiproston API manufacturers, exporters, distributors and traders.
click here to find a list of Etiproston suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Etiproston Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Etiproston GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Etiproston GMP manufacturer or Etiproston GMP API supplier for your needs.
A Etiproston CoA (Certificate of Analysis) is a formal document that attests to Etiproston's compliance with Etiproston specifications and serves as a tool for batch-level quality control.
Etiproston CoA mostly includes findings from lab analyses of a specific batch. For each Etiproston CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Etiproston may be tested according to a variety of international standards, such as European Pharmacopoeia (Etiproston EP), Etiproston JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Etiproston USP).
